Supplementary Information Tables 2016-17 : Health Canada

Table of Contents

• Overview of the federal government's approach to sustainable development
  1. Overview of the federal government's approach to sustainable development
  2. Our Departmental Sustainable Development Strategy
  3. Departmental performance highlights
     • Theme I: Addressing Climate Change and Air Quality
     • Theme II Maintaining Water Quality and Availability
     • Theme III Protecting Nature and Canadians
     • Theme IV: Shrinking the Environmental Footprint, beginning with the Government
  4. Strategic Environmental Assessment (SEA)
• Details on Transfer Payment Programs of $5 Million or More
  • Contributions for First Nations and Inuit Health Infrastructure Support (Voted)
  • Contributions for First Nations and Inuit Primary Health Care (Voted)
  • Contributions for First Nations and Inuit Supplementary Health Benefits (Voted)
  • Territorial Health Investment Fund (Voted)
  • Substance Use and Addictions Program (Voted)
  • Canada Brain Research Fund to Advance Knowledge for the Treatment of Brain Disorders (Voted)
  • Canadian Blood Services: Blood Research and Development Program (Voted)
  • Contribution to the Canadian Agency for Drugs and Technologies in Health (Voted)
  • Contribution to the Canadian Foundation for Healthcare Improvement (Voted)
  • Contribution to the Canadian Institute for Health Information (Voted)
  • Contribution to the Canadian Partnership Against Cancer (Voted)
  • Contribution to the Canadian Patient Safety Institute (Voted)
  • Grant to support the Mental Health Commission of Canada (Voted)
  • Health Care Policy Contribution Program (Voted)
  • Official Languages Health Contribution Program (Voted)
  • Thalidomide Survivors Contribution Program (Voted)
  • Contribution to Canada Health Infoway (Voted)
• Horizontal Initiatives
  • Chemicals Management Plan
  • Federal Tobacco Control Strategy
  • Jordan's Principle - A Child-First Initiative
• Internal Audits and Evaluations
  • [Table A] Internal audits completed in 2016-17
  • [Table B] Evaluations in progress or completed in 2016-17
  • Response to Parliamentary Committees and External Audits
  • Response to audits conducted by the Auditor General (including to the Commissioner of the Environment and Sustainable Development)
  • Response to audits conducted by the Public Service Commission of Canada or the Office of the Commissioner of Official Languages
• Up-Front Multi Year Funding
  • Conditional Grant to Canada Health Infoway
  • Conditional Grant to Canadian Foundation for Healthcare Improvement
• User Fees, Regulatory Charges and external fees
  • Reporting on the User Fees Act
    • Fee Right to Sell Drugs Fee
    • Drug Establishment Licensing Fees
    • Drug Submission Evaluation Fees (Pharmaceuticals and Biologic Products)
    • Medical Device License Application Fees
    • Fee for Right to Sell a Licensed Medical Device
    • Medical Device Establishment Licensing Fees
    • Veterinary Drug Evaluation Fees
    • Fees charged for filing a claim for exemption under the Hazardous Materials Information Review Act
    • Pest Control Product Application Examination Service
    • Right or Privilege to manufacture or sell a Pest Control Product in Canada and for Establishing a Maximum Residue Limit in relation to a Pest Control Product
    • Fees for processing requests filed under the Access to Information Act
    • External Fees (Policy on Service Standards for External Fees)